Learn more about our portfolio of services and innovative therapies by visiting the product websites or by downloading patient or prescribing information.
For Spanish translation, click here.
Therapies
Our innovative therapies are advancing the treatment of diseases
| Visit Websites ? | Prescribing Information | Patient Info/ Med Guide | Patent Information |
|---|---|---|---|
| Abraxane? (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) | Prescribing Information | Patient Info/ Med Guide | Patent Information |
| Idhifa? (enasidenib) | Prescribing Information | Patient Info/ Med Guide | Patent Information |
| Inrebic? (fedratinib) | Prescribing Information | Patient Info/ Med Guide | Patent Information |
| Istodax? (romidepsin) | Prescribing Information | Patient Info/ Med Guide | Patent Information |
| Otezla? (apremilast) | Prescribing Information | Patent Information | |
| Pomalyst? (pomalidomide) | Prescribing Information | Patient Info/ Med Guide | Patent Information |
| REBLOZYL? (luspatercept-aamt) | Prescribing Information | ||
| Revlimid? (lenalidomide) | Prescribing Information | Patient Info/ Med Guide | Patent Information |
| Thalomid? (thalidomide) | Prescribing Information | Patient Info/ Med Guide | Patent Information |
| VIDAZA? (azacitidine) | Prescribing Information | ||
ABRAXANE?, IDHIFA?, INREBIC?, ISTODAX?, OTEZLA?,?POMALYST?, REBLOZYL?, REVLIMID?, THALOMID?, VIDAZA? are registered trademarks of Celgene Corporation. IDHIFA? is licensed from Agios Pharmaceuticals, Inc. These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed in Global Office Network under About). | |||